SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-142285
Filing Date
2024-05-20
Accepted
2024-05-20 08:38:53
Documents
15
Period of Report
2024-05-17
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d842347d8k.htm   iXBRL 8-K 43869
2 EX-3.1 d842347dex31.htm EX-3.1 8663
3 EX-3.2 d842347dex32.htm EX-3.2 145365
  Complete submission text file 0001193125-24-142285.txt   361371

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA alpn-20240517.xsd EX-101.SCH 2890
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE alpn-20240517_lab.xml EX-101.LAB 18740
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alpn-20240517_pre.xml EX-101.PRE 11734
18 EXTRACTED XBRL INSTANCE DOCUMENT d842347d8k_htm.xml XML 3852
Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Filer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37449 | Film No.: 24962518
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)